JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1995; 25:1089-1096
© 1995 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jugdutt, B.
Right arrow Articles by Blinston, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jugdutt, B.
Right arrow Articles by Blinston, G.

Combined captopril and isosorbide dinitrate during healing after myocardial infarction. Effect on ventricular remodeling, function, mass and collagen

BI Jugdutt, MI Khan, SJ Jugdutt, and GE Blinston

Department of Medicine, University of Alberta, Edmonton, Canada.

OBJECTIVES. We sought to compare the effects of captopril plus isosorbide dinitrate versus monotherapy on infarct collagen content and left ventricular remodeling and function during healing after myocardial infarction. BACKGROUND. Captopril or isosorbide dinitrate monotherapy can limit postinfarction dilation. Whether captopril inhibits infarct collagen content, or whether captopril plus isosorbide dinitrate might be more beneficial, is not known. METHODS. In vivo remodeling variables and function (echocardiography), hemodynamic variables, postmortem topography (planimetry) and collagen content (hydroxyproline) were measured in 48 chronically instrumented dogs that were randomized 2 days after left anterior descending coronary artery ligation to 6 weeks of therapy with captopril, isosorbide dinitrate, captopril plus isosorbide dinitrate or placebo. RESULTS. Compared with placebo, the three active therapies decreased blood pressure and left atrial pressure; limited infarct expansion, infarct thinning, noninfarct wall stretching and thickening; limited left ventricular dilation and increase in left ventricular mass; and decreased regional bulging, aneurysm frequency and left ventricular dysfunction. However, the decrease in asynergy and increase in volume ejection fraction were less with captopril or captopril plus isosorbide dinitrate than with isosorbide dinitrate. Infarct thinning and bulging at 6 weeks was also less with isosorbide dinitrate than with captopril. Although initial left ventricular asynergy, final scar sizes and noninfarct collagen content at 6 weeks were similar among the groups, collagen in the center of the infarct scar was less with captopril or captopril plus isosorbide dinitrate than with placebo or isosorbide dinitrate. CONCLUSIONS. Monotherapy with captopril or isosorbide dinitrate, or their combination, improved all remodeling variables, but isosorbide dinitrate improved function more than captopril or captopril plus isosorbide dinitrate. Inhibition of infarct collagen content by captopril suggests that benefits with captopril represent a balance between positive and negative effects, and its combination with isosorbide dinitrate might be advantageous.


This article has been cited by other articles:


Home page
J CARDIOVASC PHARMACOL THERHome page
B. I. Jugdutt and V. Menon
Beneficial Effects of Therapy on the Progression of Structural Remodeling During Healing After Reperfused and Nonreperfused Myocardial Infarction: Different Effects on Different Parameters
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2002; 7(2): 95 - 107.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
B. I. Jugdutt
Monocytosis and adverse left ventricular remodeling after reperfused myocardial infarction
J. Am. Coll. Cardiol., January 16, 2002; 39(2): 247 - 250.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R.-K. Li, D. A.G. Mickle, R. D. Weisel, V. Rao, and Z.-Q. Jia
Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury
Ann. Thorac. Surg., December 1, 2001; 72(6): 1957 - 1963.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
W. M. Park, C. P. Connery, J. S. Hochman, M. D. Tilson, and C. E. Anagnostopoulos
Successful repair of myocardial free wall rupture after thrombolytic therapy for acute infarction
Ann. Thorac. Surg., October 1, 2000; 70(4): 1345 - 1349.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. J. Mahmarian, L. A. Moye, D. A. Chinoy, R. F. Sequeira, G. B. Habib, W. J. Henry, A. Jain, B. R. Chaitman, C. S. W. Weng, H. Morales-Ballejo, et al.
Transdermal Nitroglycerin Patch Therapy Improves Left Ventricular Function and Prevents Remodeling After Acute Myocardial Infarction : Results of a Multicenter Prospective Randomized, Double-Blind, Placebo-Controlled Trial
Circulation, May 26, 1998; 97(20): 2017 - 2024.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1995 by the American College of Cardiology Foundation.